Novo Nordisk Must Face Shareholder Fraud Claims Over CagriSema Disappointment
Companies

Novo Nordisk Must Face Shareholder Fraud Claims Over CagriSema Disappointment

A U.S. judge ruled that Novo Nordisk must answer investor fraud allegations after the obesity drug trial missed its weig...

Declan Byrne 👁 50 💬 0
Amgen Settles Shareholder Suit Over Undisclosed $10.7B Tax Bill for $74 Million
Companies

Amgen Settles Shareholder Suit Over Undisclosed $10.7B Tax Bill for $74 Million

The biotech giant resolves a class action alleging it hid a massive potential tax liability from investors, with the und...

Declan Byrne 👁 64 💬 0